Skip to main content

Table 2 Demographics and clinical characteristics in the PP Population

From: The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation

Parameter

Statistic

NaturaLyte

GranuFlo

Total (All Treated)

Patient number (Per Protocol Population)

N

10

10

11

Age (years)

Mean (SD)

53.1 (10.82)

54.9 (8.77)

53.1 (10.26)

Median

50.5

52

51

Min, Max

35.0, 75.0

47.0, 75.0

35.0, 75.0

Sex

 Female

n (%)

3 (30.0)

4 (40.0)

4 (36.4)

 Male

n (%)

7 (70.0)

6 (60.0)

7 (63.6)

Race

 American Indian or Alaska Native

n (%)

0 (0.0)

0 (0.0)

0 (0.0)

 Asian

n (%)

0 (0.0)

0 (0.0)

0 (0.0)

 Black

n (%)

8 (80.0)

9 (90.0)

9 (81.8)

 Native Hawaiian or other Pacific Islander

n (%)

0 (0.0)

0 (0.0)

0 (0.0)

 White

n (%)

2 (20.0)

1 (10.0)

2 (18.2)

Ethnic Group

 Hispanic or Latino

n (%)

0 (0.0)

0 (0.0)

0 (0.0)

 Not Hispanic or Latino

n (%)

10 (100.0)

10 (100.0)

11 (100.0)

Weight (kg)

Mean (SD)

84.4 (20.35)

88.1 (23.09)

87.6 (21.99)

Median

82.1

88.5

82.3

Min, Max

50.5, 120.3

50.5, 120.3

50.5, 120.3

Height (cm)

Mean (SD)

164.5 (10.85)

167.4 (11.06)

166.0 (11.45)

Median

162.7

168.3

166.4

Min, Max

151.9, 185.9

151.9, 185.9

151.9, 185.9

BMI (kg/m2)

Mean (SD)

31.2 (7.32)

31.3 (7.39)

31.7 (7.12)

Median

31.3

31.3

32.1

Min, Max

21.9, 47.6

21.9, 47.6

21.9, 47.6